Risk for at least one adverse event per patient · schizophrenia
It is very uncertain whether summary of findings table ‐ CBT without antipsychotics changes adverse events ‐ Participants with at least one AE (separated time… compared with antipsychotics (very low certainty).
1 finding from 1 review
Mental state · schizophrenia
1 finding from 1 review
Global state ‐ number of participants with relapse/exacerbations of psychosis (separated time points) ‐ < 12 months · schizophrenia
It is very uncertain whether summary of findings table ‐ CBT without antipsychotics changes global state ‐ number of participants with relapse/exacerbations of… compared with CBT plus antipsychotics (very low certainty).
1 finding from 1 review
Leaving the study early/ loss to · schizophrenia
It is very uncertain whether summary of findings table ‐ CBT without antipsychotics changes leaving the study early ‐ for any reason ‐ overall acceptability… compared with CBT plus antipsychotics (very low certainty).
1 finding from 1 review
Level of functioning · schizophrenia
1 finding from 1 review
Risk for at least one adverse event per patient · schizophrenia
Summary of findings table ‐ CBT without antipsychotics may leads to lower adverse events ‐ Participants with at least one AE (separated time… compared with CBT plus antipsychotics (low certainty).
1 finding from 1 review
Global state ‐ number of participants with relapse/exacerbations of psychosis (separated time points) ‐ > 1 year · schizophrenia
Summary of findings table ‐ CBT without antipsychotics showed no clear difference in global state ‐ number of participants with relapse/exacerbations of… compared with no specific treatment (low certainty).
1 finding from 1 review
Leaving the study early/ loss to · schizophrenia
Summary of findings table ‐ CBT without antipsychotics showed no clear difference in leaving the study early ‐ for any reason ‐ overall acceptability… compared with no specific treatment (low certainty).
1 finding from 1 review
Level of functioning · schizophrenia
1 finding from 1 review
Risk for at least one adverse event per patient · schizophrenia
1 finding from 1 review
Mental state · schizophrenia
1 finding from 1 review
Global state ‐ number of participants with relapse/exacerbations of psychosis (separated time points) ‐ < 12 months · schizophrenia
It is very uncertain whether summary of findings table ‐ CBT without antipsychotics changes global state ‐ number of participants with relapse/exacerbations of… compared with antipsychotics (very low certainty).
1 finding from 1 review
Leaving the study early/ loss to · schizophrenia
It is very uncertain whether summary of findings table ‐ CBT without antipsychotics changes leaving the study early ‐ for any reason ‐ overall acceptability… compared with antipsychotics (very low certainty).
1 finding from 1 review
Level of functioning · schizophrenia
1 finding from 1 review
Global state: clinically important change in global state · people with the acute phase of schizophrenia
It is very uncertain whether magnetic seizure therapy plus standard care changes global state: clinically important change assessed by: number of… compared with electroconvulsive therapy plus standard care (very low certainty).
1 finding from 1 review
Cognitive functioning: clinically important change ‐ not measured · people with the acute phase of schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects: clinically important adverse effectsassessed by: number of participants with a delayed memory deficitStudy duration: 4 weeks · people with the acute phase of schizophrenia
It is very uncertain whether magnetic seizure therapy plus standard care changes adverse effects: clinically important adverse effectsassessed by:… compared with electroconvulsive therapy plus standard care (very low certainty).
1 finding from 1 review
Quality of life: clinically important change ‐ not measured · people with the acute phase of schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Social functioning: clinically important change ‐ not measured · people with the acute phase of schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dropout · people with the acute phase of schizophrenia
It is very uncertain whether magnetic seizure therapy plus standard care changes leaving the study early: any reasonassessed by: number of dropouts… compared with electroconvulsive therapy plus standard care (very low certainty).
1 finding from 1 review